U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07867938) titled 'A Clinical Trial of Tulisokibart (MK-7240) in Participants With Pulmonary Sarcoidosis (MK-7240-016)' on Oct. 05.
Brief Summary: Researchers are looking for new ways to treat active pulmonary sarcoidosis (PS).
This trial will help researchers learn if a trial medicine called tulisokibart can treat symptoms of active PS. The goal of this trial is to learn if tulisokibart works better than placebo to increase the length of time until PS gets worse.
Study Start Date: Nov. 06
Study Type: INTERVENTIONAL
Condition:
Pulmonary Sarcoidosis
Intervention:
DRUG: Tulisokibart
Subcutaneous (SC) administration
OTHER: Placebo
SC administra...